Dr Reddy's Laboratories on Monday said its Switzerland-based subsidiary has completed the acquisition of Haleon plc's global ...

Hyderabad-based Dr Reddy's Laboratories (DRL) posted a 9.5 per cent year-on-year (Y-o-Y) decline in its consolidated profit ...

RDY misses on earnings but beats on revenues in the fiscal second quarter. The bottom line suffers due to a one-time ...

Indian generic drugmaker Dr Reddy's Laboratories recorded a 9.5 percent decline in its consolidated net profit after tax to ...

No-moat Dr. Reddy’s reported mixed second-quarter earnings ... Reddy’s closed the nicotine therapy portfolio acquisition from Haleon. Management noted that business integration is underway ...

I was alarmed by a recent Star guest commentary that leveled a number of false attacks against Dr. Prasanth Reddy. The ...

Haleon To Offload Non-Core Nicotine Therapy Business To Dr. Reddy's For Over $600M Haleon has agreed to sell its nicotine replacement therapy business outside the U.S. to Dr. Reddy's Laboratories ...

HYDERABAD/BENGALURU (Reuters) -Indian generic drugmaker Dr Reddy's Laboratories' second-quarter ... Nicotinell, from Haleon in June. During the quarter, the company had charged off a debt tax ...

Dr. Reddy’s Laboratories’ (DRL ... Acquisition of NRT business from Haleon, consolidation of Sanofi’s vaccine portfolio ...